Literature DB >> 21191018

JNK1 is required for lentivirus entry and gene transfer.

Meng-Horng Lee1, Roshan Padmashali, Stelios T Andreadis.   

Abstract

Although a lot of progress has been made in development of lentiviral vectors for gene therapy, the interactions of these vectors with cellular factors have not been explored adequately. Here we show that lentivirus infection phosphorylates JNK and that blocking the kinase activity of JNK decreases gene transfer in a dose-dependent manner, regardless of the viral envelope glycoprotein. Knockdown by small interfering RNA (siRNA) revealed that JNK1 but not JNK2 was required for productive gene transfer. The effect of JNK on gene transfer was not due to changes in the cell cycle, as JNK knockdown did not affect the cell cycle profile of target cells and even increased cell proliferation. In addition, confluent cell monolayers also exhibited JNK phosphorylation upon lentivirus infection and a dose-dependent decrease in gene transfer efficiency upon JNK inhibition. On the other hand, JNK activation was necessary for lentivirus internalization into the cell cytoplasm, while inhibition of JNK activity decreased virus entry without affecting binding to the cell surface. These experiments suggest that JNK is required for lentivirus entry into target cells and may have implications for gene transfer or for development of antiviral agents.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21191018      PMCID: PMC3067971          DOI: 10.1128/JVI.01765-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Influenza virus-induced AP-1-dependent gene expression requires activation of the JNK signaling pathway.

Authors:  S Ludwig; C Ehrhardt; E R Neumeier; M Kracht; U R Rapp; S Pleschka
Journal:  J Biol Chem       Date:  2001-01-09       Impact factor: 5.157

2.  JNK signaling pathway is required for efficient wound healing in Drosophila.

Authors:  Mika Rämet; René Lanot; Daniel Zachary; Pascal Manfruelli
Journal:  Dev Biol       Date:  2002-01-01       Impact factor: 3.582

3.  HIV Tat activates c-Jun amino-terminal kinase through an oxidant-dependent mechanism.

Authors:  Y Gu; R F Wu; Y C Xu; S C Flores; L S Terada
Journal:  Virology       Date:  2001-07-20       Impact factor: 3.616

4.  Inhibition of JNK activation through NF-kappaB target genes.

Authors:  G Tang; Y Minemoto; B Dibling; N H Purcell; Z Li; M Karin; A Lin
Journal:  Nature       Date:  2001-11-15       Impact factor: 49.962

5.  The p150-Spir protein provides a link between c-Jun N-terminal kinase function and actin reorganization.

Authors:  I M Otto; T Raabe; U E Rennefahrt; P Bork; U R Rapp; E Kerkhoff
Journal:  Curr Biol       Date:  2000-03-23       Impact factor: 10.834

Review 6.  The JNK signal transduction pathway.

Authors:  Claire R Weston; Roger J Davis
Journal:  Curr Opin Genet Dev       Date:  2002-02       Impact factor: 5.578

7.  Receptor binding transforms the surface subunit of the mammalian C-type retrovirus envelope protein from an inhibitor to an activator of fusion.

Authors:  A L Barnett; J M Cunningham
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

8.  Differential requirement for the stress-activated protein kinase/c-Jun NH(2)-terminal kinase in RNAdamage-induced apoptosis in primary and in immortalized fibroblasts.

Authors:  M S Iordanov; J Wong; D L Newton; S M Rybak; R K Bright; R A Flavell; R J Davis; B E Magun
Journal:  Mol Cell Biol Res Commun       Date:  2000-08

9.  Matrix survival signaling: from fibronectin via focal adhesion kinase to c-Jun NH(2)-terminal kinase.

Authors:  E A Almeida; D Ilić; Q Han; C R Hauck; F Jin; H Kawakatsu; D D Schlaepfer; C H Damsky
Journal:  J Cell Biol       Date:  2000-05-01       Impact factor: 10.539

10.  Visualization of the intracellular behavior of HIV in living cells.

Authors:  David McDonald; Marie A Vodicka; Ginger Lucero; Tatyana M Svitkina; Gary G Borisy; Michael Emerman; Thomas J Hope
Journal:  J Cell Biol       Date:  2002-11-04       Impact factor: 10.539

View more
  6 in total

1.  Novel lentiviral-inducible transgene expression systems and versatile single-plasmid reporters for in vitro and in vivo cancer biology studies.

Authors:  W H Shuen; R Kan; Z Yu; H L Lung; M L Lung
Journal:  Cancer Gene Ther       Date:  2015-02-27       Impact factor: 5.987

2.  Mismatch in mechanical and adhesive properties induces pulsating cancer cell migration in epithelial monolayer.

Authors:  Meng-Horng Lee; Pei-Hsun Wu; Jack Rory Staunton; Robert Ros; Gregory D Longmore; Denis Wirtz
Journal:  Biophys J       Date:  2012-06-19       Impact factor: 4.033

Review 3.  Ex vivo gene therapy for HIV-1 treatment.

Authors:  Lisa J Scherer; John J Rossi
Journal:  Hum Mol Genet       Date:  2011-04-19       Impact factor: 6.150

4.  JNK1 Derived from Orange-Spotted Grouper, Epinephelus coioides, Involving in the Evasion and Infection of Singapore Grouper Iridovirus (SGIV).

Authors:  Minglan Guo; Jingguang Wei; Xiaohong Huang; Yongcan Zhou; Yang Yan; Qiwei Qin
Journal:  Front Microbiol       Date:  2016-02-10       Impact factor: 5.640

5.  Adherens junction formation inhibits lentivirus entry and gene transfer.

Authors:  Roshan Padmashali; Hui You; Nikhila Karnik; Pedro Lei; Stelios T Andreadis
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

6.  Normal mammary epithelial cells promote carcinoma basement membrane invasion by inducing microtubule-rich protrusions.

Authors:  Meng-Horng Lee; Pei-Hsun Wu; Daniele Gilkes; Ivie Aifuwa; Denis Wirtz
Journal:  Oncotarget       Date:  2015-10-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.